Computed Tomography-Based Radiomics Using Tumor and Vessel Features to Assess Resectability in Cancer of the Pancreatic Head

• Published in: Diagnostics (Basel) Vol. 13; no. 20; p. 3198
• Main Authors: Litjens, Geke, Broekmans, Joris P. E. A, Boers, Tim, Caballo, Marco, van den Hurk, Maud H. F, Ozdemir, Dilek, van Schaik, Caroline J, Janse, Markus H. A, van Geenen, Erwin J. M, van Laarhoven, Cees J. H. M, Prokop, Mathias, de With, Peter H. N, van der Sommen, Fons, Hermans, John J
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.10.2023; MDPI
• Subjects: adenocarcinoma; Bile ducts; Cancer; Chemotherapy; computed tomography; CT imaging; Diagnosis; Metastasis; oncology; pancreas; Pancreatic cancer; Radiomics; resectability; Surgery; Tomography; Tumors; Veins & arteries; Netherlands; Taiwan
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics13203198

The preoperative prediction of resectability pancreatic ductal adenocarcinoma (PDAC) is challenging. This retrospective single-center study examined tumor and vessel radiomics to predict the resectability of PDAC in chemo-naïve patients. The tumor and adjacent arteries and veins were segmented in the portal-venous phase of contrast-enhanced CT scans, and radiomic features were extracted. Features were selected via stability and collinearity testing, and least absolute shrinkage and selection operator application (LASSO). Three models, using tumor features, vessel features, and a combination of both, were trained with the training set (N = 86) to predict resectability. The results were validated with the test set (N = 15) and compared to the multidisciplinary team’s (MDT) performance. The vessel-features-only model performed best, with an AUC of 0.92 and sensitivity and specificity of 97% and 73%, respectively. Test set validation showed a sensitivity and specificity of 100% and 88%, respectively. The combined model was as good as the vessel model (AUC = 0.91), whereas the tumor model showed poor performance (AUC = 0.76). The MDT’s prediction reached a sensitivity and specificity of 97% and 84% for the training set and 88% and 100% for the test set, respectively. Our clinician-independent vessel-based radiomics model can aid in predicting resectability and shows performance comparable to that of the MDT. With these encouraging results, improved, automated, and generalizable models can be developed that reduce workload and can be applied in non-expert hospitals.